Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study.

HF HFpEF OSA biomarkers comorbidity cytokines heart failure obstructive phenotype prognosis sleep apnea

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
23 Feb 2023
Historique:
received: 01 02 2023
revised: 17 02 2023
accepted: 20 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Heart failure with preserved ejection fraction (HFpEF) and obstructive sleep apnea (OSA) frequently co-occur and this comorbidity represents a separate phenotype of HFpEF. While many research attempts are focused on biomarkers of HFpEF, currently, there is a lack of validated biomarkers of HFpEF and OSA. In this study, we aimed to evaluate prognostic significance of several serum cytokines in patients with HFpEF and OSA. The patients with HFpEF and OSA were recruited from the Sleep Apnea Center of Novosibirsk, Russian Federation and followed up for 12 months. The main analyzed outcomes were five-point major adverse cardiovascular events (MACE) and the 6-min walk test (6MWT). The analyzed cytokines were circulating IL-6, IL-10, and VEGF measured at baseline. We recruited 77 male patients with HFpEF and OSA, the data of 71 patients were available for analyses. Patients who developed MACE had four-fold elevated concentrations of serum IL-10. There was no association between baseline cytokine levels and longitudinal changes in 6MWT. Circulating IL-10 levels are positively associated with MACE in men with HFpEF and OSA and thus may be a potential prognostic biomarker in this subgroup of patients. These results should be confirmed in larger studies encompassing both males and females.

Identifiants

pubmed: 36983783
pii: life13030628
doi: 10.3390/life13030628
pmc: PMC10051341
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Inflam. 2017;2017:4309485
pubmed: 28487810
Front Cardiovasc Med. 2019 Feb 28;6:15
pubmed: 30873415
Front Physiol. 2022 Aug 22;13:967169
pubmed: 36072844
J Transl Med. 2015 Apr 24;13:129
pubmed: 25903806
BMC Med Res Methodol. 2021 Nov 6;21(1):241
pubmed: 34742250
J Immunol. 2008 May 1;180(9):5771-7
pubmed: 18424693
Circ Res. 2017 Apr 14;120(8):1243-1245
pubmed: 28408453
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
ESC Heart Fail. 2021 Oct;8(5):3855-3864
pubmed: 34382750
Mediators Inflamm. 2015;2015:493409
pubmed: 25944984
Eur J Heart Fail. 2019 Aug;21(8):965-973
pubmed: 31087601
Circulation. 2005 Dec 13;112(24):3738-44
pubmed: 16330684
Circ Res. 2018 Aug 17;123(5):614-629
pubmed: 30355136
Aust J Gen Pract. 2019 Jul;48(7):465-471
pubmed: 31256507
J Card Fail. 2011 May;17(5):420-5
pubmed: 21549300
ESC Heart Fail. 2020 Apr;7(2):503-511
pubmed: 31951323
Physiol Rev. 2006 Apr;86(2):515-81
pubmed: 16601268
PLoS One. 2012;7(10):e46423
pubmed: 23110049
J Am Heart Assoc. 2017 Mar 30;6(4):
pubmed: 28360225
Int J Mol Sci. 2022 Jan 15;23(2):
pubmed: 35055117
Am J Med. 2011 Aug;124(8):724-30
pubmed: 21787901
Ann Occup Hyg. 2014 Nov;58(9):1126-42
pubmed: 25261453
PLoS One. 2014 Apr 15;9(4):e94188
pubmed: 24736635
Circ Res. 2021 May 14;128(10):1451-1467
pubmed: 33983831
Eur Heart J. 2005 Apr;26(8):778-93
pubmed: 15774495
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):170-8
pubmed: 24425702
J Palliat Med. 2015 May;18(5):447-52
pubmed: 25871624
Auton Autacoid Pharmacol. 2002 Apr;22(2):83-92
pubmed: 12568125
Isr Med Assoc J. 2010 Mar;12(3):158-62
pubmed: 20684180
Int J Mol Sci. 2019 Jan 22;20(3):
pubmed: 30678164
Eur J Heart Fail. 2009 Jun;11(6):602-8
pubmed: 19468022
J Clin Sleep Med. 2010 Oct 15;6(5):420-1
pubmed: 20957839
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16
pubmed: 24789549
J Clin Sleep Med. 2022 Jan 1;18(1):67-73
pubmed: 34216197
Adv Sci (Weinh). 2021 Aug;8(15):e2004433
pubmed: 34114369
Heart. 2007 Sep;93(9):1137-46
pubmed: 17699180
Eur Respir J. 2022 May 12;59(5):
pubmed: 34949696
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719870084
pubmed: 31441375
Curr Heart Fail Rep. 2017 Aug;14(4):235-250
pubmed: 28707261
Sleep. 2002 Feb 1;25(1):59-65
pubmed: 11833862
Front Immunol. 2020 Jul 21;11:1343
pubmed: 32793188
Sleep Breath. 2015 Dec;19(4):1327-33
pubmed: 25903074
ESC Heart Fail. 2021 Feb;8(1):662-669
pubmed: 33300277
Thromb Haemost. 2015 Mar;113(3):505-12
pubmed: 25373619
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
J Allergy Clin Immunol. 2022 Aug;150(2):251-258
pubmed: 35934679
JACC Heart Fail. 2017 Oct;5(10):715-723
pubmed: 28888522

Auteurs

Alexey Yakovlev (A)

Department of Therapy, Hematology and Transfusiology, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, Russia.
Cardiology Department, Non-State Healthcare Institution "Road Clinical Hospital in Novosibirsk", Russian Railways Joint Stock Company, Vladimirovsky Spusk, 630003 Novosibirsk, Russia.

Alexander Teplyakov (A)

Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, Russia.

Elena Grakova (E)

Department of Myocardial Pathology, Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, Russia.

Sergey Shilov (S)

Department of Pathological Physiology and Clinical Pathophysiology, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, Russia.

Natalia Yakovleva (N)

Department of Policlinic Therapy and General Medical Practice, Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, Russia.

Kristina Kopeva (K)

Department of Myocardial Pathology, Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Kievskaya Str., 111a, 634012 Tomsk, Russia.

Valery Shirinsky (V)

Laboratory of Clinical Immunopharmacology, Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology, 6 Zalesskogo Str., 630099 Novosibirsk, Russia.

Ivan Shirinsky (I)

Laboratory of Clinical Immunopharmacology, Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology, 6 Zalesskogo Str., 630099 Novosibirsk, Russia.

Classifications MeSH